Market Overview:
The global advanced wound care market size reached US$ 10.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 14.4 Billion by 2028, exhibiting a growth rate (CAGR) of 5.98% during 2023-2028.
Advanced wound care is a standard medical solution that provides specialized treatment for chronic infections and non-healing wounds by removing dead and inflamed tissues. It includes medications, equipment, and several products that help treat acute and chronic wounds, such as burns, ulcers, and post-operative wounds. Advanced wound care products comprising silver and alginates are extensively used to remove excess fluids from wounds and protect them from infections. They include hydrogels, hydrocolloids, film and foam dressings, and alginates. They help retain skin moisture and facilitate quick healing of wounds internally and externally by promoting the growth of body cells.
.webp)
Advanced Wound Care Market Trends:
The increasing global geriatric population and the rising prevalence of pressure ulcers, diabetic foot ulcers, and other chronic wounds are among the key factors positively influencing the market. Chronic wounds are complex and non-healing infections that fail to progress through the healing phases in an orderly sequence. In addition, the increasing occurrence of diabetes, obesity, and a significant surge in the need for surgical procedures across the globe are catalyzing the demand for advanced wound care products as they help absorb necrotic tissues, which are highly effective in the rapid healing of surgical site infections. In line with this, the rising awareness among individuals about the proven benefits and effectiveness of these products is increasing their sales worldwide. Apart from this, technological advancements in advanced wound care products are contributing to market growth. For instance, nanoparticle-based wound healing and skin regeneration bioactive molecules over the applied area maintain the drug release and improve the therapeutic effects of drugs. Furthermore, the expansion of Ambulatory Surgical Centers (ASCs) that provide diagnostics, preventive procedures, and surgical care for pain management, orthopedics, urology, restorative, organ transplantation, and reconstructive surgeries, is propelling the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global advanced wound care market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, application and end user.
Breakup by Product:
- Infection Management
- Silver Wound Dressings
- Non-silver Dressings
- Collagen Dressings
- Exudate Management
- Hydrocolloids Dressings
- Foam Dressings
- Alginate Dressings
- Hydrogel Dressings
- Active Wound Care
- Skin Substitutes
- Growth Factors
- Therapy Devices
- Negative Pressure Wound Therapy (NPWT)
- Oxygen and Hyperbaric Oxygen Equipment
- Electromagnetic Therapy Devices
- Others
Breakup by Application:
- Chronic Wounds
- Pressure Ulcers
- Diabetic Foot Ulcers
- Venous Leg Ulcers
- Arterial Ulcers
- Acute Wounds
- Burns and Trauma
- Surgical Wounds
Breakup by End User:
- Hospitals
- Community Health Service Centers
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, B. Braun SE (B. Braun Holding GmbH & Co. KG), Cardinal Health, Inc., Coloplast A/S, Convatec Group plc, Essity AB, Integra LifeSciences, Medline Industries, LP, Medtronic plc, Mölnlycke Health Care (Investor AB), Organogenesis Holdings Inc. and Smith & Nephew plc.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2022 |
Historical Period |
2017-2022 |
Forecast Period |
2023-2028 |
Units |
US$ Billion |
Segment Coverage |
Product, Application, End User, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
3M Company, B. Braun SE (B. Braun Holding GmbH & Co. KG), Cardinal Health, Inc., Coloplast A/S, Convatec Group plc, Essity AB, Integra LifeSciences, Medline Industries, LP, Medtronic plc, Mölnlycke Health Care (Investor AB), Organogenesis Holdings Inc. and Smith & Nephew plc. |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |